Immunocore Holdings IMCR
NASDAQ IMCR
$32.17 +0.08 (+0.26%)
As of: Oct 22, 2026 · 9:40 AM EDT

Immunocore Holdings (IMCR) Long-Term Debt Issuances (2024)

Updated

Immunocore Holdings' Long-Term Debt Issuances was $402.5 million in Q1 2024.

Analysis

Immunocore Holdings (IMCR) Long-Term Debt Issuances (2024) Analysis & Trends

For FY2022, Long-Term Debt Issuances at Immunocore Holdings came in at $51.03 million.

  • In earlier years, Long-Term Debt Issuances was $49.57 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,152.37 Bn 1,120.96 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 628.86 Bn 547.39 Bn 17.26 Bn -
3 AbbVie 500.37 Bn 473.48 Bn 12.70 Bn -
4 Merck 374.01 Bn 328.39 Bn 12.21 Bn -
5 Novartis Ag 300.56 Bn 264.55 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 263.92 Bn 237.60 Bn 12.86 Bn -
7 Amgen 238.37 Bn 193.77 Bn 7.24 Bn -
8 Gilead Sciences 192.21 Bn 166.40 Bn 6.22 Bn -
9 Pfizer 171.20 Bn 117.84 Bn 10.94 Bn -
10 Immunocore Holdings 1.64 Bn -1.85 Bn 114.84 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 402.50 Mn
API Access

Immunocore Holdings Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=IMCR&period=max&api_key=YOUR_API_KEY